IPS

(redirected from Induced Pluripotent Stem Cell)
Also found in: Dictionary, Medical, Acronyms, Wikipedia.
Related to Induced Pluripotent Stem Cell: in vitro

IPS

Abbrev. for interplanetary scintillation. See scattering.

IPS

1. Abbr. for “iron-pipe size”; a nominal dimension, inside diameter.
2. Abbr. for “International Pipe Standard.”
3. Abbr. for “inside pipe size.”

IPS

A threaded language.

["IPS, An Unorthodox High Level Language", K. Meinzer, BYTE pp. 146-159 (Jan 1979)].

IPS

(1) See indoor positioning system.

(2) (Inches Per Second) The measurement of the speed of tape passing by a read/write head or paper passing through a pen plotter.

(3) (Intrusion Prevention System) Software that prevents an attack on a network or computer system. It is a significant step beyond an intrusion detection system (IDS). Whereas an IDS passively monitors traffic by sniffing packets at a switch port, an IPS resides inline like a firewall, intercepting and forwarding packets. It is thus capable of blocking the attack in real time. See IDS.

(4) (In-Plane Switching) An LCD technology that provides better color reproduction and greater viewing angles than twisted nematic (TN) screens. See IPS panel.

(5) See also ISP.
References in periodicals archive ?
discovery that induced pluripotent stem cells (iPS) could be generated from
Perhaps the most distinctive feature of this report are the breakthrough findings discovered as a result of surveying 293 researchers that identify as having induced pluripotent stem cells as their core research focus.
There are currently four major areas of commercialization for induced pluripotent stem cells, as described below:
com is pleased to announce the publishing of a recent report by BioInformant Worldwide on induced pluripotent stem cells.
Vitro manufactures and sells "Tools for Stem Cell and Drug Development[TM]", including human mesenchymal stem cells and derivatives, optimized media for sustained self-renewal, lineage-specific differentiation and products supporting induced pluripotent stem cell and cancer research.
We manufacture and sell "Tools for Stem Cell and Drug Development[TM]," including human mesenchymal stem cells and derivatives, optimized media for sustained self-renewal, and products supporting induced pluripotent stem cell and cancer research.
This includes 2-day courses on mesenchymal stem cell biology (October 2nd and 3rd), mammary stem cell biology (October 17th and 18th), neural stem cell biology (October 30th and 31st), hematopoietic stem cell biology (October 30th and 31st), and human embryonic and induced pluripotent stem cell biology (November 14th and 15th).
html) has recently added the market intelligence report titled " The Complete 2012-13 Induced Pluripotent Stem Cell Industry Report - Market Metrics, Dynamics, and Trends.
Research and Markets has announced the addition of the "Complete 2012-13 Induced Pluripotent Stem Cell Industry Report" report to their offering.
VIRxSYS Corporation announced today that the company has received a grant from the Maryland Stem Cell Research Commission to develop safer methods for induced pluripotent stem cell (iPS) using the company's proprietary spliceosome-mediated RNA trans-splicing (SMaRT[TM]) and lentiviral gene delivery platform technologies.